This inventor holds 5 USPTO granted patents. Top assignees: Repligen Corporation, Other. Active years: 1988-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1988-2004
Title: Bernard Rimland: Pioneering Innovations in Autism Treatment
Introduction
Bernard Rimland was a notable inventor and researcher based in San Diego, CA. He is recognized for his significant contributions to the treatment of autism and other neurological disorders. With a total of 5 patents, Rimland's work has had a lasting impact on the field of medicine.
Latest Patents
Rimland's latest patents focus on the use of secretin and its compositions for treating autism and other neurological, behavioral, and immunological disorders. One of his methods involves administering an effective amount of secretin, such as Secretin-Ferring, to patients. In one example, 2 clinical units (CU) of Secretin-Ferring were dissolved in a 7.5 ml solution of sodium chloride and intravenously injected over one minute. Another method involved transdermal administration, where dimethyl sulfoxide (DMSO) was applied to the patient's skin, and about 15 CU of Secretin-Ferring was rubbed into the DMSO. Other methods for administering secretin include using gels, lotions, patches, oral carriers like tablets and capsules, inhalation, suppository forms, and even acoustic waves to enhance skin penetration.
Career Highlights
Throughout his career, Rimland made significant strides in understanding and treating autism. His innovative approaches have paved the way for new treatment methodologies that continue to influence the medical community.
Collaborations
Rimland collaborated with notable individuals such as Victoria Beck and Fred Rosen, contributing to the advancement of research in his field.
Conclusion
Bernard Rimland's work in the treatment of autism through innovative methods has left a profound legacy in medical research. His patents and collaborations have opened new avenues for understanding and addressing neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile